Annual SGA
$15.46 M
-$3.51 M-18.49%
December 1, 2024
Summary
- As of March 12, 2025, UBX annual SGA is $15.46 million, with the most recent change of -$3.51 million (-18.49%) on December 1, 2024.
- During the last 3 years, UBX annual SGA has fallen by -$7.60 million (-32.95%).
- UBX annual SGA is now -35.65% below its all-time high of $24.02 million, reached on December 31, 2020.
Performance
UBX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$4.25 M
+$436.00 K+11.43%
December 1, 2024
Summary
- As of March 12, 2025, UBX quarterly SGA is $4.25 million, with the most recent change of +$436.00 thousand (+11.43%) on December 1, 2024.
- Over the past year, UBX quarterly SGA has increased by +$436.00 thousand (+11.43%).
- UBX quarterly SGA is now -34.90% below its all-time high of $6.53 million, reached on September 30, 2020.
Performance
UBX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.00 B
-$25.99 M-1.32%
December 1, 2024
Summary
- As of March 12, 2025, UBX TTM SGA is -$2.00 billion, with the most recent change of -$25.99 million (-1.32%) on December 1, 2024.
- Over the past year, UBX TTM SGA has dropped by -$2.01 billion (-12894.18%).
- UBX TTM SGA is now -2199.51% below its all-time high of -$86.88 million.
Performance
UBX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
UBX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.5% | +11.4% | -10000.0% |
| 3 y3 years | -33.0% | -19.5% | -9636.5% |
| 5 y5 years | -22.9% | -19.5% | -9636.5% |
UBX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -33.0% | at low | -26.8% | +20.9% | -31.7% | at low |
| 5 y | 5-year | -35.6% | at low | -34.9% | +20.9% | -132.1% | at low |
| alltime | all time | -35.6% | +200.9% | -34.9% | +105.4% | -2199.5% | at low |
Unity Biotechnology Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $15.46 M(-18.5%) | $4.25 M(+11.4%) | $15.46 M(-1.0%) |
| Sep 2024 | - | $3.81 M(+8.5%) | $15.62 M(-3.3%) |
| Jun 2024 | - | $3.52 M(-9.3%) | $16.15 M(-10.5%) |
| Mar 2024 | - | $3.88 M(-12.0%) | $18.04 M(-4.9%) |
| Dec 2023 | $18.97 M(-9.5%) | $4.41 M(+1.4%) | $18.96 M(-4.4%) |
| Sep 2023 | - | $4.35 M(-19.7%) | $19.84 M(-2.8%) |
| Jun 2023 | - | $5.41 M(+12.8%) | $20.41 M(+2.4%) |
| Mar 2023 | - | $4.80 M(-9.1%) | $19.94 M(-4.8%) |
| Dec 2022 | $20.95 M(-9.1%) | $5.28 M(+7.3%) | $20.95 M(+0.8%) |
| Sep 2022 | - | $4.92 M(-0.4%) | $20.77 M(-3.8%) |
| Jun 2022 | - | $4.94 M(-14.9%) | $21.60 M(-4.6%) |
| Mar 2022 | - | $5.81 M(+13.8%) | $22.64 M(-1.8%) |
| Dec 2021 | $23.06 M(-4.0%) | $5.10 M(-11.2%) | $23.06 M(-0.5%) |
| Sep 2021 | - | $5.75 M(-3.9%) | $23.18 M(-3.3%) |
| Jun 2021 | - | $5.98 M(-4.0%) | $23.96 M(-1.4%) |
| Mar 2021 | - | $6.23 M(+19.2%) | $24.30 M(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $24.02 M(+19.8%) | $5.22 M(-20.0%) | $24.02 M(+1.3%) |
| Sep 2020 | - | $6.53 M(+3.3%) | $23.71 M(+3.7%) |
| Jun 2020 | - | $6.32 M(+6.2%) | $22.87 M(+6.3%) |
| Mar 2020 | - | $5.95 M(+21.3%) | $21.52 M(+7.4%) |
| Dec 2019 | $20.05 M(+25.2%) | $4.91 M(-13.8%) | $20.05 M(+3.0%) |
| Sep 2019 | - | $5.69 M(+14.5%) | $19.47 M(+7.2%) |
| Jun 2019 | - | $4.97 M(+11.0%) | $18.16 M(+6.6%) |
| Mar 2019 | - | $4.48 M(+3.4%) | $17.04 M(+6.4%) |
| Dec 2018 | $16.02 M(+66.5%) | $4.33 M(-1.4%) | $16.02 M(+12.3%) |
| Sep 2018 | - | $4.39 M(+14.2%) | $14.27 M(+15.4%) |
| Jun 2018 | - | $3.84 M(+11.1%) | $12.36 M(+12.3%) |
| Mar 2018 | - | $3.46 M(+34.1%) | $11.00 M(+14.4%) |
| Dec 2017 | $9.62 M(+87.2%) | $2.58 M(+3.7%) | $9.62 M(+36.6%) |
| Sep 2017 | - | $2.48 M(-0.0%) | $7.04 M(+54.5%) |
| Jun 2017 | - | $2.48 M(+20.0%) | $4.55 M(+120.0%) |
| Mar 2017 | - | $2.07 M | $2.07 M |
| Dec 2016 | $5.14 M | - | - |
FAQ
- What is Unity Biotechnology annual SGA?
- What is the all time high annual SGA for Unity Biotechnology?
- What is Unity Biotechnology annual SGA year-on-year change?
- What is Unity Biotechnology quarterly SGA?
- What is the all time high quarterly SGA for Unity Biotechnology?
- What is Unity Biotechnology quarterly SGA year-on-year change?
- What is Unity Biotechnology TTM SGA?
- What is the all time high TTM SGA for Unity Biotechnology?
- What is Unity Biotechnology TTM SGA year-on-year change?
What is Unity Biotechnology annual SGA?
The current annual SGA of UBX is $15.46 M
What is the all time high annual SGA for Unity Biotechnology?
Unity Biotechnology all-time high annual SGA is $24.02 M
What is Unity Biotechnology annual SGA year-on-year change?
Over the past year, UBX annual SGA has changed by -$3.51 M (-18.49%)
What is Unity Biotechnology quarterly SGA?
The current quarterly SGA of UBX is $4.25 M
What is the all time high quarterly SGA for Unity Biotechnology?
Unity Biotechnology all-time high quarterly SGA is $6.53 M
What is Unity Biotechnology quarterly SGA year-on-year change?
Over the past year, UBX quarterly SGA has changed by +$436.00 K (+11.43%)
What is Unity Biotechnology TTM SGA?
The current TTM SGA of UBX is -$2.00 B
What is the all time high TTM SGA for Unity Biotechnology?
Unity Biotechnology all-time high TTM SGA is -$86.88 M
What is Unity Biotechnology TTM SGA year-on-year change?
Over the past year, UBX TTM SGA has changed by -$2.01 B (-12894.18%)